Objective: Viral encephalitis increases the risk for developing seizures and epilepsy. Indoleamine 2,3-dioxygenase 1 (Ido1) is induced by inflammatory cytokines and functions to metabolize tryptophan to kynurenine. Kynurenine can be further metabolized to produce kynurenic acid and the N-methyl-D-aspartate receptor agonist quinolinic acid (QuinA). In the present study, we sought to determine the role of Ido1 in promoting seizures in an animal model of viral encephalitis. Methods: C57BL/6J and Ido1 knockout mice (Ido1-KO) were infected with Theiler's murine encephalomyelitis virus (TMEV). Quantitative real-time polymerase chain reaction was used to evaluate hippocampal expression of proinflammatory cytokines, Ido1, and viral RNA. Body weights and seizure scores were recorded daily. Elevated zero maze was used to assess differences in behavior, and hippocampal pathology was determined by immunohistochemistry. Results: Infected C57BL/6J mice up-regulated proinflammatory cytokines, Ido1, and genes encoding the enzymatic cascade responsible for QuinA production in the kynurenine pathway prior to the onset of seizures. Seizure incidence was elevated in Ido1-KO compared to C57BL/6J mice. Infection increased locomotor activity in Ido1-KO compared to C57BL/6J mice. Furthermore, the occurrence of seizures was associated with hyperexcitability. Neither expression of proinflammatory cytokines nor viral RNA was altered as a result of genotype. Immunohistochemical analysis revealed increased hippocampal pathology in Ido1-KO mice. Significance: Our findings suggest that Ido1 deletion promotes seizures and neuropathogenesis during acute TMEV encephalitis.
a diagnosis of encephalitis was reportedly 22% if the patient experienced an acute seizure during encephalitis and 10% in those who had not exhibited seizures during acute encephalitis. 3 Although viral-induced epilepsy represents a substantial burden, the mechanisms whereby viral infection promotes the development of seizures (ictogenesis) and persistence of seizures (epileptogenesis) are incompletely understood.
Theiler's murine encephalomyelitis virus (TMEV) is a member of the family Picornaviridae. Intracerebral inoculation of C57BL/6J mice with TMEV causes loss of neurons in the hippocampal CA1 region. Neuronal death is dependent on neuroinflammation (monocyte influx and proinflammatory cytokine production within the brain), but does not involve direct viral lysis of neurons. [4] [5] [6] Unlike other models of viral encephalitis, almost all mice survive infection, but depending on the strain and titer of TMEV, between 40% and 70% of infected mice will develop seizures between 2 and 7 days post infection (p.i.). Despite a lack of viral persistence, some of the mice will develop epilepsy with unprovoked seizures evident for at least 7 months p.i. 7 In this model, ictogenesis is associated with the up-regulation of cytokines, including interferons (IFNs), tumor necrosis factor (TNF), and interleukin (IL)-6.
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Together, these traits make TMEV an excellent model with which to study the pathogenesis of viral-induced seizures and concomitant neuropathology. Indoleamine 2,3-dioxygenase 1 (Ido1) metabolizes tryptophan (Trp) to kynurenine (Kyn). Although basal levels of Ido1 vary between tissue location and cell type, the expression of this enzyme is highly inducible by inflammatory mediators, in particular type II (IFN-γ) IFNs.
11 Ido1 induction may lead to focal depletion of Trp at the site of inflammation or infection, which can directly limit viral replication. 11 The intracellular Kyn generated by Ido1 is either released or metabolized into downstream "kynurenines" (kynurenic acid [KynA] or quinolinic acid [QuinA]), which have both neuro-and immunomodulatory consequences. 12, 13 Extracellular KynA serves as an N-methyl-Daspartate (NMDA) receptor antagonist and is considered neuroprotective. Conversely, QuinA is a glutamatergic NMDA receptor agonist and can evoke neurotoxic and ictogenic responses. 14 Thus, during viral encephalitis, Ido1 may excerpt a positive effect (via Trp depletion and KynA production) or negative effect (via QuinA production). With this dichotomy in mind, the objective of the current study was to determine the role of Ido1 during the pathogenesis of TMEV-induced seizures and neuropathology. The current literature would suggest that Ido1 induction would drive seizure onset, incidence, and severity by a mechanism involving the production of QuinA. Surprisingly, global inactivation of Ido1 was associated with an increased incidence of seizures during infection with TMEV.
| MATERIALS AND METHODS

| Animals
All animal care protocols were in accordance with National Institutes of Health Guidelines for Care and Use of Laboratory Animals and were approved by the University of Illinois Laboratory Animal Care and Use Committee. Male 5-to 6-week-old mice were used for all experiments. C57BL/ 6J (Jackson Laboratories, No. 000664) and Ido1 knockout (Ido1-KO; Jackson Laboratories, No. 005867) mice on a C57BL/6J background were group-housed in solid-bottom caging with standard bedding (Teklad, 1/8′′ corncob) under temperature-controlled conditions (23 ± 1°C) with 12-hour reversed light/dark cycles (10 AM-10 PM). Rodent diet (Teklad, No. 8640) and water were provided ad libitum. At the end of each experiment, mice were anesthetized via intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg). After reaching a surgical plane of anesthesia, they were perfused through the heart with sterile phosphate-buffered saline (PBS; pH 7.4).
| TMEV growth, titration, and infection
The BeAn 8386 strain of TMEV (Dr Jane Welsh, Department of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX) was used for all experiments. The virus was propagated in baby hamster kidney (BHK)-21 cells. Briefly, monolayers were incubated with TMEV (one multiplicity of infection) diluted in Delbecco modified eagle medium supplemented with antibiotics and 0.5% bovine serum albumin (Sigma-Aldrich) for 1 hour at room temperature with constant rocking. The virus was aspirated, then fresh medium was added. After 48 hours, medium was frozen then thawed. Cell debris was removed by centrifugation at 12 000 g for 15 minutes at 4°C. Virus was aliquoted and stored at −80°C. Viral titer was determined by standard plaque assay on BHK-21 cells. 15 Mice were infected as described previously. 16 In brief, mice were anesthetized with 4% isoflurane (Phoenix/Clipper), then inoculated with either sterile viral growth medium or with
Key Points
• For experiments shown in Figure 5 , hippocampal RNA was isolated using TriReagent (Sigma-Aldrich) according to the manufacturer's instructions. Total RNA was treated with DNase I (Thermo Fisher Scientific), and cDNA was obtained using the Reverse Transcription System (Promega) according to the manufacturer's instructions. Samples were then screened for contaminating DNA by PCR using β-actin-specific primers and Phusion High-Fidelity DNA Polymerase (New England BioLabs) using a C1000 Touch Thermal Cycler (Bio-Rad Laboratories). RT-qPCR was performed to determine expression levels of proinflammatory cytokines (Ifng, Tnf, and Il6) and virus (Tmev). Products were amplified using iTaq Universal SYBR Green Supermix (Bio-Rad Laboratories) on a StepOnePlus Real-Time PCR System thermocycler (Applied Biosystems). Gene F I G U R E 1 Effect of Theiler's murine encephalomyelitis virus (TMEV) infection on hippocampal cytokines and Ido1-mediated pathway activation. C57BL/6J mice were either sham-inoculated (blue, n = 7) or TMEV-infected (orange, n = 6). Hippocampal expression was determined by real-time quantitative polymerase chain reaction at day 2 post infection. Levels of Tnf, Il6, Il1b, and Ifng (A), Ido1-FL (B), and Kmo, Kynu, Haao, and Kat2 (C) are shown. **P < 0.01, ***P < 0.001 sham versus TMEV expression was normalized using β-actin. For all experiments, fold change was calculated using the formula 2
−ΔΔCt
. Materials are shown in Table S1 .
| Immunohistochemistry
Following perfusion, whole brains were immersed in 4% paraformaldehyde in PBS. After 24 hours, brains were transferred into PBS containing 30% sucrose (wt/vol) and stored at 4°C until cryoprotected. Brain tissue was then bisected coronally and frozen in Tissue-Tek O.C.T. Compound (VWR International). Next, 10-μm-thick sections were prepared using a CM1950 cryostat (Leica Biosystems), collected on Superfrost Plus Microscope Slides (Thermo Fisher Scientific), and stored at −80°C. At the time of staining, sections were rehydrated with PBS for 15 minutes then blocked and permeabilized with PBS containing 0.3% Triton-X 100 (PBST; Sigma-Aldrich) supplemented with 5% goat serum (Abcam) for 1 hour at room temperature. Sections were then incubated with primary antibody (NeuN, 3 μg/mL, Abcam) overnight at 4°C. The following day, the slides were washed three times with PBST then incubated with an Alexa Fluor 488-labeled antibody in PBST (goat antirabbit IgG, 2 μg/mL, Thermo Fisher Scientific) for 1 hour at room temperature. After washing, nuclei were then counterstained for 1 minute (Hoechst 33342, 5 μg/mL, Thermo Fisher Scientific). Slides were washed, then glass coverslips were added using Fluoromount-G solution (SouthernBiotech). Fluorescent images were captured on an Observer.Z1 fluorescence microscope (Carl Zeiss) using AxioVision (release 4.6) software (Carl Zeiss). Images were opened in ImageJ (National Institutes of Health), and the number of NeuN +-Hoechst + double-positive cells per field of vision (20× magnification) were obtained from C57BL/6J (n = 3) and Ido1-KO (n = 3) mice using the counter application. Analysis was performed across anatomically similar (bregma −1.34 to −2.06) hippocampal images (n = 5-17). For each mouse, the average number of double-positive hippocampal CA1 neurons obtained from the left and right cerebral hemisphere was determined.
| Statistical analysis
Data are expressed as mean ± standard error. Statistical analysis was performed using Prism (GraphPad, v7.0) software. Differences in seizure incidence were determined by the chi-square test. Unpaired t test was used to test the effect of treatment on Ido1-FL expression. Three-way analysis of variance (ANOVA) was used to test the effects of genotype (C57BL/6J and Ido1-KO), treatment (sham and TMEV), and time (day p.i.) on body weight. Two-way ANOVA followed by Bonferroni post hoc test was used to determine differences in behavior and neuropathology. One-way ANOVA followed by Kruskal-Wallis post hoc test was used to assess differences in cytokine data. In all cases, P < 0.05 was considered statistically significant.
| RESULTS
| TMEV induces cytokines, Ido1, and genes that encode enzymes in the Kyn pathway
Ido1 is up-regulated following stimulation with proinflammatory cytokines. Therefore, we first measured cytokine expression in the hippocampus prior to the development of seizures. In C57BL/6J mice, compared to sham inoculation, TMEV infection increased expression of Tnf, Il6, Il1b, and Ifng at day 2 p.i. ( Figure 1A ). Next, we questioned whether TMEV induces Ido1 expression in the brains of mice. Ido1 expression is essentially absent in hippocampi of naive mice. However, Ido1 expression was dramatically up-regulated during infection ( Figure 1B ). Ido1 is rate-limiting for Trp metabolism to Kyn, which is subsequently catabolized to QuinA by the enzymes Kyn 3-monooxygenase (KMO), kynureninase (KYNU), and 3-hydroxyanthranilate 3,4-dioxygnase (HAAO). Alternatively, Kyn can be converted to KynA by Kyn aminotransferase II (KAT2). Interestingly, Kynu, Kmo, and Haao expression was increased in the hippocampus of mice infected with TMEV ( Figure 1C) . However, expression of Kat2 did not differ from sham-inoculated C57BL/6J mice. These data indicate that TMEV may activate the enzymatic pathway responsible for QuinA production.
| Ido1 deletion promotes TMEV-induced seizures
QuinA is an NMDA receptor agonist and has been known for a long time to promote ictogenesis. 14 We hypothesized that inactivation of Ido1 would confer protection against virus-induced seizures. To determine whether Ido1 modulated seizure induction during viral encephalitis, we inoculated C57BL/6J and Ido1-KO mice with vehicle or TMEV and monitored daily for seizures. Importantly, sham inoculation did not cause seizures (data not shown). However, 41% of TMEV-infected C57BL/6J mice exhibited seizures within 6 days versus 74% of infected Ido1-KO mice (Figure 2A) . Examination of cumulative seizure burden has been efficacious in evaluating seizure severity and number over time. 18 We found that cumulative seizure burden was greater in Ido1-KO mice compared to C57BL/6J mice at day 6 p.i. (Figure 2B ). There were no significant differences in cumulative seizure burden among mice that experienced seizures ( Figure 2C ). These data indicate that although the lack of Ido1 increased the incidence of ictogenesis, it did not affect either the frequency or severity of seizures.
| Effect of Ido1 on body weight and behavior during TMEV infection
Infection caused a transient reduction in body weight when compared to sham inoculation. However, the absence of Ido1 neither affected weight loss nor recovery ( Figure 3 ). To determine whether genetic deletion of Ido1 influenced behavior, C57BL/6J and Ido1-KO mice were subjected to two separate trials of EZM spaced 8 days apart to mimic analyses performed on infected animals. There were no significant differences in distance traveled, although there was a strong trend toward an effect of genotype ( Figure S1A and S1B). Ido1-KO mice entered the open areas fewer times and spent less time in the open areas than C57BL/6J mice ( Figure S1C and S1D). These data indicate that Ido1-KO mice exhibit slightly more anxietylike behavior than C57BL/6 mice. Anxietylike behavior between C57BL/6J and Ido1-KO mice was evaluated using an EZM at days 6 and 14 p. Figure 4E-G) . Moreover, infected Ido1-KO mice traveled further than infected C57BL/6 mice ( Figure 4H ). Collectively, these data suggest that acute TMEV infection may F I G U R E 2 Ido1-deficient mice exhibit increased seizure incidence compared to C57BL/6J mice. A, C57BL/6J (blue; n = 34) and Ido1-knockout (KO) (orange; n = 31) mice were intracerebrally infected with Theiler's murine encephalomyelitis virus. Seizure incidence indicates percentage of mice having experienced at least one seizure (Racine score ≥ 3). ***P < 0.001 C57BL/6J versus Ido1-KO. B, C, Cumulative seizure burden compounded daily for all mice (B) and only for mice that developed seizures (C). ### P < 0.001 C57BL/6J versus Ido1-KO
F I G U R E 3 Intracerebral infection
decreased body weight. C57BL/6J (blue) and Ido1-knockout (KO; orange) mice were either sham-inoculated (n = 10) or Theiler's murine encephalomyelitis virus (TMEV)-infected (n = 32-38). Body weight is expressed as percentage change relative to baseline from three independent experiments decrease anxietylike behavior. However, an alternative explanation is that mice with seizures are more hyperactive. It appeared that mice that developed seizures were generally more mobile than mice in which seizures were not observed ( Figure 4A-H) .
To dissect the relationship between seizure incidence and hyperactivity, we evaluated locomotion of mice with or without seizures. To perform this analysis, we collapsed the data across time, because only two Ido1-KO mice in this cohort remained seizure-free at day 14 p.i. Using this approach, we found that mice that displayed clinical seizures were less hesitant in their first exploration of the open area than those without seizures ( Figure 4I ). Furthermore, C57BL/6J mice that seized spent more time in the open area than those that had not seized. This effect was not apparent in Ido1-KO mice ( Figure 4J ). Likewise, it appeared that C57BL/6J mice that experienced seizures had an increased number of entries into the open area compared to those that had not seized, but this effect did not reach statistical significance ( Figure 4K) . Finally, mice with documented seizures moved a greater distance than those for which we did not observe seizures ( Figure 4L ). When collapsing the data in this fashion, infected Ido1-KO mice were less hesitant to explore open areas of the maze, entered the open areas more often, and traveled more distance than infected C57BL/6J mice ( Figure 4I, 4K, and  4L) . Collectively, these data indicate that during acute TMEV infection hyperexcitability is associated with the occurrence of seizures 19 and generally lend support for our observation that seizure incidence is increased in Ido1-KO mice.
| The effect of Ido1 on proinflammatory cytokine and viral RNA levels in the hippocampus
We next questioned whether the lack of Ido1 altered expression of proinflammatory cytokines in the hippocampus at days 8 and 16 p.i. Expression of proinflammatory cytokines were not different between genotypes (Figure 5A-C) . Moreover, viral RNA levels were not different between C57BL/6J and Ido1-KO mice at day 8 p.i. At day 16 p.i., viral RNA appeared to be reduced in Ido1-KO mice compared with C57BL/6J controls but the effect did not reach statistical significance ( Figure 5D ).
| Deletion of Ido1 exacerbates hippocampal damage
Infection of C57BL/6J mice with TMEV causes cell death of hippocampal CA1 neurons. 5 Having demonstrated seizure incidence is affected by the lack of Ido1, we next questioned whether the absence of this enzyme altered hippocampal neuropathology. To test whether this was the case, we counted the number of NeuN + Hoechst + cells in hippocampal CA1 and CA2 of infected C57BL/6J and Ido1-KO mice. In control mice, the number of NeuN + cells did not differ between mouse strains ( Figure S2A and S2B). At day 14 p.i., Ido1-KO mice had reduced numbers of CA1 hippocampal neurons compared to C57BL/6J mice ( Figure 6A and 6B ). In contrast, there was no effect of genotype on the numbers of neurons in CA2 ( Figure 6C and 6D). These findings suggest that during acute viral encephalitis, the lack of Ido1 decreases survival of hippocampal neurons.
| DISCUSSION
In this study, we investigated the role of Ido1 in an animal model of virus-induced ictogenesis. We found that TMEV infection of C57BL/6J mice increased hippocampal expression of the proinflammatory cytokines Tnf, Il6, Il1b, and Ifng. Moreover, we observed increased hippocampal expression of full-length Ido1 as well as Kynu, Kmo, and Haao as a result of infection whereas Kat2 levels remained unchanged. These results suggest that TMEV infection induces the enzymatic pathway responsible for QuinA production. Injection of the NMDA receptor agonist QuinA can cause seizures. 14 Therefore, we disrupted the Kyn pathway using an Ido1 global knockout mouse model to test whether inhibition of an enzyme upstream of QuinA would decrease seizure susceptibility or neuropathogenesis during TMEV infection. We demonstrated that mice lacking Ido1 had an increased seizure incidence compared to C57BL/6J mice. Finally, we found that infected Ido1-KO mice displayed increased neuronal pathology within hippocampal CA1 compared with C57BL/6J mice. Collectively, our data suggest Ido1 plays a protective role during virus-induced ictogenesis. The current data are the first to provide evidence that indicates genetic deletion of Ido1 increases the incidence of seizures during acute TMEV infection of C57BL/6J mice. Genetic background is known to play a role in the pathogenesis of TMEV-induced neurological diseases, which has been recently exemplified through the use of the Collaborative Cross mouse population. 20 Importantly, all mice used in this study were on the C57BL/6J background. Although it is beyond the scope of the current study, given the seemingly protective role of Ido1 in mitigating the occurrence of TMEV-induced seizures during acute infection, it would be interesting to compare the expression of this gene in mouse strains that are resistant to seizures (ie, SJL). It has been reported that Ido1 promotes depressionlike behavior in a rat model of temporal lobe epilepsy. 21 However, its ability to modulate seizure incidence and severity in animal models of epilepsy other than TMEV has not been fully elucidated. An important next step will be to determine the effects of Ido1 deletion on TMEV-induced epileptogenesis and the development of depressionlike behaviors in mice that exhibit unprovoked seizures following viral clearance. As reported previously, infection with the BeAn 8386 strain of TMEV caused a transient loss in body weight. 16 Despite that the absence of Ido1 increased the incidence of seizures, we did not observe changes in body weight between Ido1-KO and C57BL6/J mice. Nonetheless, our results indicate that locomotor behavior was increased in mice with documented seizures. These results appear to be consistent with Theiler and Gard's characterization of disease following infection with the FA strain insofar as mice with seizures exhibited hyperexcitability. 19 Our behavioral analysis indicated that mice that exhibited at least one observed seizure moved greater distances than mice that remained "seizure-free." In a previous study, TMEV-inoculated mice exhibited increased anxietylike behavior when compared to sham-inoculated mice. 22 Anxietylike behavior in this study was assessed using the light/dark box test and open field analysis, during the light phase. In contrast, we found that TMEV-inoculated mice displayed increased activity in the EZM compared to sham-inoculated controls. A potentially important difference between these studies is that our testing occurred during the dark phase, when mice are typically active. Furthermore, our findings suggest that increased activity among infected animals was associated with the occurrence of seizures. This observation is interesting and may be indicative of a manic state rather than decreased anxiety. Mania is associated with both increased activity (here measured as distance traveled) and risk-taking behaviors (here measured as time spent in open, lighted areas of an elevated maze). Moreover, mania occurs as a result of temporal lobe seizures as well as during viral encephalitis. 23 Neuroinflammation has emerged as a contributor to both ictogenesis and epileptogenesis. 24 Specifically, Toll-like receptor agonists (ie, high mobility group box 1), danger associated molecular pattern receptor agonists (ie, P2X7), inflammatory cytokines (ie, IL-1β, TNF, IL-6, and TGFβ1), chemokines (ie, CCL2, CCL5, CCL3), cyclooxygenase-2, and prostaglandins have recently received attention for their ability to modulate seizure onset and progression in humans and in preclinical models. 25, 26 Given their association with neuroinflammation, it is not surprising that many viruses that infect the central nervous system (CNS) can contribute to seizure onset and increase the risk for developing epilepsy. 27 However, how viruses convey this effect has not been fully elucidated. Cytokines increase astrocyte chemokine production. 28 Subsequent up-regulation of chemokines attract inflammatory monocytes to the CNS that contribute to neuronal death and seizure onset. 29 Alternatively, cytokines and chemokines may interact with neurons and/or astrocytes to directly modulate synaptic activity. 25, 30 It is likely that there is no single molecular event that entirely accounts for the effects of neuroinflammation on seizure risk. Rather, it appears that a cascade of events underlies this effect. In the current study, we build on the understanding of how inflammation contributes to seizure onset during viral infection by demonstrating that deficiency of cytokine-dependent Ido1 was associated with increased seizure incidence and greater neuron loss but had no effect on hippocampal cytokine expression. A caveat of this study is that hippocampal cytokines were measured at day 8 p.i., after the generation of seizures. It is not yet known whether deletion of Ido1 affects immune cell trafficking to the brain or cytokine production in the brain prior to seizure onset. Furthermore, it is not known whether global Ido1 depletion affects the generation of TMEV-specific adaptive immunity. This is the subject of current investigation.
Given that Ido1 is a known interferon-stimulated gene, it is not surprising that it is up-regulated during viral encephalitis. Ido1 expression is increased by other viruses that cause encephalitis and postencephalitic epilepsy, 31 but the outcome of this effect is obscure. Interestingly, concomitant stimulation of both human astrocytoma (86HG39) and cervical cancer epithelial (HeLa) cell lines with TNF and IFN-γ induced Ido1 expression and inhibited herpes simplex 2 virus replication. 32 Moreover, during experimental West Nile virus infection, Ido1 was up-regulated within cells adjacent to virally infected cells in a manner dependent on type I interferon production. The increase in Ido1 expression corresponded to decreased intracellular Trp, which inhibited viral replication. 31 Data derived from in vivo studies also indicate that Ido1 is up-regulated during viral encephalitis. For instance, intraperitoneal injection with encephalomyocarditis virus increased Ido1 expression in the cerebellum, where it colocalized to areas of reactive gliosis. 33 Moreover, peripheral infection with Japanese encephalitis virus (JEV) increased Ido1 expression in the periphery and brain, and Ido1-KO mice were more resistant to encephalitis. 11 Although the authors from the latter study mentioned the occurrence of seizures caused by JEV, the effect of Ido1 on the incidence and/or severity of these seizures was not reported. Therefore, it remains to be determined whether Ido1 protection against viral encephalitic pathogenesis is specific for members of Picornaviridae.
In conclusion, Ido1 is increased in the hippocampus of mice infected with TMEV. Preventing this induction by global deletion of Ido1 was associated with increased incidence of seizures, altered behavior, and exacerbated neuronal pathology following TMEV infection. Although we have not yet determined the mechanism governing these observations, our data strongly suggest that a lack of Ido1 is detrimental during TMEV infection, as it promoted ictogenesis and neuropathology.
